Logo image of BDX

BECTON DICKINSON AND CO (BDX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BDX - US0758871091 - Common Stock

191.82 USD
-2.2 (-1.13%)
Last: 12/1/2025, 8:04:00 PM
191.82 USD
0 (0%)
After Hours: 12/1/2025, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, BDX scores 5 out of 10 in our fundamental rating. BDX was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While BDX has a great profitability rating, there are quite some concerns on its financial health. BDX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BDX had positive earnings in the past year.
BDX had a positive operating cash flow in the past year.
Each year in the past 5 years BDX has been profitable.
Each year in the past 5 years BDX had a positive operating cash flow.
BDX Yearly Net Income VS EBIT VS OCF VS FCFBDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.03%, BDX is in the better half of the industry, outperforming 76.60% of the companies in the same industry.
With an excellent Return On Equity value of 6.61%, BDX belongs to the best of the industry, outperforming 80.32% of the companies in the same industry.
The Return On Invested Capital of BDX (5.61%) is better than 78.19% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BDX is below the industry average of 8.72%.
The last Return On Invested Capital (5.61%) for BDX is above the 3 year average (5.35%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROIC 5.61%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.35%
ROIC(5y)5.07%
BDX Yearly ROA, ROE, ROICBDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

The Profit Margin of BDX (7.68%) is better than 78.72% of its industry peers.
BDX's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 13.86%, BDX belongs to the best of the industry, outperforming 82.98% of the companies in the same industry.
In the last couple of years the Operating Margin of BDX has grown nicely.
BDX has a worse Gross Margin (45.44%) than 61.17% of its industry peers.
In the last couple of years the Gross Margin of BDX has remained more or less at the same level.
Industry RankSector Rank
OM 13.86%
PM (TTM) 7.68%
GM 45.44%
OM growth 3Y-0.5%
OM growth 5Y7.2%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y-0.11%
GM growth 5Y0.46%
BDX Yearly Profit, Operating, Gross MarginsBDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BDX is destroying value.
The number of shares outstanding for BDX has been reduced compared to 1 year ago.
BDX has less shares outstanding than it did 5 years ago.
BDX has a better debt/assets ratio than last year.
BDX Yearly Shares OutstandingBDX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
BDX Yearly Total Debt VS Total AssetsBDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

BDX has a debt to FCF ratio of 7.18. This is a slightly negative value and a sign of low solvency as BDX would need 7.18 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.18, BDX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
BDX has a Debt/Equity ratio of 0.69. This is a neutral value indicating BDX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.69, BDX is doing worse than 68.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 7.18
Altman-Z N/A
ROIC/WACC0.74
WACC7.53%
BDX Yearly LT Debt VS Equity VS FCFBDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 1.11 indicates that BDX should not have too much problems paying its short term obligations.
BDX has a worse Current ratio (1.11) than 86.70% of its industry peers.
BDX has a Quick Ratio of 1.11. This is a bad value and indicates that BDX is not financially healthy enough and could expect problems in meeting its short term obligations.
BDX has a Quick ratio of 0.64. This is amonst the worse of the industry: BDX underperforms 90.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.64
BDX Yearly Current Assets VS Current LiabilitesBDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. Growth

3.1 Past

BDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.57%, which is quite good.
The Earnings Per Share has been growing slightly by 7.19% on average over the past years.
BDX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.23%.
The Revenue has been growing slightly by 6.32% on average over the past years.
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%

3.2 Future

The Earnings Per Share is expected to grow by 7.68% on average over the next years.
BDX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.70% yearly.
EPS Next Y3.94%
EPS Next 2Y5.8%
EPS Next 3Y6.36%
EPS Next 5Y7.68%
Revenue Next Year4.3%
Revenue Next 2Y4.35%
Revenue Next 3Y2.61%
Revenue Next 5Y3.7%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BDX Yearly Revenue VS EstimatesBDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BDX Yearly EPS VS EstimatesBDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.30, the valuation of BDX can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of BDX indicates a rather cheap valuation: BDX is cheaper than 89.36% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BDX to the average of the S&P500 Index (26.11), we can say BDX is valued slightly cheaper.
The Price/Forward Earnings ratio is 12.80, which indicates a correct valuation of BDX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BDX indicates a rather cheap valuation: BDX is cheaper than 89.89% of the companies listed in the same industry.
BDX is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.3
Fwd PE 12.8
BDX Price Earnings VS Forward Price EarningsBDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BDX is valued cheaper than 84.57% of the companies in the same industry.
87.77% of the companies in the same industry are more expensive than BDX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.59
EV/EBITDA 13.39
BDX Per share dataBDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BDX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.38
PEG (5Y)1.85
EPS Next 2Y5.8%
EPS Next 3Y6.36%

6

5. Dividend

5.1 Amount

BDX has a Yearly Dividend Yield of 2.17%.
BDX's Dividend Yield is rather good when compared to the industry average which is at 1.71. BDX pays more dividend than 96.81% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, BDX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

The dividend of BDX has a limited annual growth rate of 3.17%.
BDX has been paying a dividend for at least 10 years, so it has a reliable track record.
BDX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.17%
Div Incr Years34
Div Non Decr Years34
BDX Yearly Dividends per shareBDX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

71.28% of the earnings are spent on dividend by BDX. This is not a sustainable payout ratio.
BDX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP71.28%
EPS Next 2Y5.8%
EPS Next 3Y6.36%
BDX Yearly Income VS Free CF VS DividendBDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
BDX Dividend Payout.BDX Dividend Payout, showing the Payout Ratio.BDX Dividend Payout.PayoutRetained Earnings

BECTON DICKINSON AND CO

NYSE:BDX (12/1/2025, 8:04:00 PM)

After market: 191.82 0 (0%)

191.82

-2.2 (-1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-03 2026-02-03
Inst Owners92.24%
Inst Owner Change4.06%
Ins Owners0.57%
Ins Owner Change1.05%
Market Cap54.98B
Revenue(TTM)21.84B
Net Income(TTM)1.68B
Analysts72.63
Price Target209.55 (9.24%)
Short Float %1.47%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend4.15
Dividend Growth(5Y)3.17%
DP71.28%
Div Incr Years34
Div Non Decr Years34
Ex-Date12-08 2025-12-08 (1.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-0.05%
Max EPS beat(2)7.13%
EPS beat(4)3
Avg EPS beat(4)5.56%
Min EPS beat(4)-0.05%
Max EPS beat(4)14.05%
EPS beat(8)7
Avg EPS beat(8)5.42%
EPS beat(12)10
Avg EPS beat(12)4.67%
EPS beat(16)13
Avg EPS beat(16)5.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.9%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-0.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.99%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)0.37%
Revenue beat(8)2
Avg Revenue beat(8)-0.95%
Revenue beat(12)5
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.46%
PT rev (1m)-5.52%
PT rev (3m)-7.67%
EPS NQ rev (1m)-12.27%
EPS NQ rev (3m)-12.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)-4.21%
Revenue NQ rev (3m)-4.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 13.3
Fwd PE 12.8
P/S 2.52
P/FCF 20.59
P/OCF 16.03
P/B 2.17
P/tB N/A
EV/EBITDA 13.39
EPS(TTM)14.42
EY7.52%
EPS(NY)14.99
Fwd EY7.81%
FCF(TTM)9.32
FCFY4.86%
OCF(TTM)11.97
OCFY6.24%
SpS76.19
BVpS88.58
TBVpS-37.08
PEG (NY)3.38
PEG (5Y)1.85
Graham Number169.53
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROCE 6.44%
ROIC 5.61%
ROICexc 5.69%
ROICexgc 25.49%
OM 13.86%
PM (TTM) 7.68%
GM 45.44%
FCFM 12.23%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.35%
ROIC(5y)5.07%
ROICexc(3y)5.52%
ROICexc(5y)5.23%
ROICexgc(3y)26.44%
ROICexgc(5y)26.65%
ROCE(3y)6.16%
ROCE(5y)5.84%
ROICexgc growth 3Y-6.54%
ROICexgc growth 5Y8%
ROICexc growth 3Y2.92%
ROICexc growth 5Y13.47%
OM growth 3Y-0.5%
OM growth 5Y7.2%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y-0.11%
GM growth 5Y0.46%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 7.18
Debt/EBITDA 3.21
Cap/Depr 30.87%
Cap/Sales 3.48%
Interest Coverage 250
Cash Conversion 62.49%
Profit Quality 159.12%
Current Ratio 1.11
Quick Ratio 0.64
Altman-Z N/A
F-Score7
WACC7.53%
ROIC/WACC0.74
Cap/Depr(3y)33.59%
Cap/Depr(5y)39.6%
Cap/Sales(3y)3.86%
Cap/Sales(5y)4.6%
Profit Quality(3y)162.63%
Profit Quality(5y)151.73%
High Growth Momentum
Growth
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
EPS Next Y3.94%
EPS Next 2Y5.8%
EPS Next 3Y6.36%
EPS Next 5Y7.68%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%
Revenue Next Year4.3%
Revenue Next 2Y4.35%
Revenue Next 3Y2.61%
Revenue Next 5Y3.7%
EBIT growth 1Y4.74%
EBIT growth 3Y4.47%
EBIT growth 5Y13.98%
EBIT Next Year22.48%
EBIT Next 3Y11.06%
EBIT Next 5Y12.3%
FCF growth 1Y-13.11%
FCF growth 3Y17.14%
FCF growth 5Y-0.73%
OCF growth 1Y-9.69%
OCF growth 3Y9.2%
OCF growth 5Y-0.62%

BECTON DICKINSON AND CO / BDX FAQ

Can you provide the ChartMill fundamental rating for BECTON DICKINSON AND CO?

ChartMill assigns a fundamental rating of 5 / 10 to BDX.


Can you provide the valuation status for BECTON DICKINSON AND CO?

ChartMill assigns a valuation rating of 6 / 10 to BECTON DICKINSON AND CO (BDX). This can be considered as Fairly Valued.


How profitable is BECTON DICKINSON AND CO (BDX) stock?

BECTON DICKINSON AND CO (BDX) has a profitability rating of 7 / 10.


What is the financial health of BECTON DICKINSON AND CO (BDX) stock?

The financial health rating of BECTON DICKINSON AND CO (BDX) is 3 / 10.


What is the expected EPS growth for BECTON DICKINSON AND CO (BDX) stock?

The Earnings per Share (EPS) of BECTON DICKINSON AND CO (BDX) is expected to grow by 3.94% in the next year.